If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
108.00    2.00 (1.89%)
Bid:
106.00
Ask:
110.00
Spread: 4.00 (3.774%)
Market Cap: £64.98m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Collaborations with VMWare and Imagination

13 Jun 2017 07:00

RNS Number : 8678H
Intercede Group PLC
13 June 2017
 

 

13 June 2017

INTERCEDE GROUP plc

("Intercede", or the "Group")

Collaborations with VMWare and Imagination

Intercede, the leading specialist in digital identity, credential management and secure mobility, is pleased to announce that it is collaborating with VMWare and Imagination on two separate, significant projects utilising Intercede's leading MyID and MyTAM software.

MyID is now available for VMware Workspace ONE and VMware AirWatch to provide U.S. Federal Government employees with secure remote access to mail, browsers and other apps on their mobile devices. To access this capability, federal government employees can use existing Personal Identity Verification (PIV) smart cards at a self-service kiosk to authenticate to the system to provision keys and certificates to their mobile devices.

Users are able to leverage Intercede's MyID technology and mobile software development kit (SDK) through a derived credentials solution for secure mobility, which provides increased mobile credentialing capability in compliance with stringent security standards for strong authentication and mobile working (FIPS 201-2 / Special Publication 800-157). More details of this collaboration can be found at https://www.intercede.com/news/intercede-collaborates-with-vmware-to-offer-secure-device-based-mobile-solution-for-u.s.-federal-government/.

Commenting on the VMWare collaboration, Richard Parris, Chairman & CEO of Intercede, said;

"Government is a highly regulated industry and one that cannot afford to be the victim of easily avoided data breaches or cyber hacks. The repercussions of poor authentication for a government department could be serious and far-reaching, which means security should never be taken lightly. Allowing customers to leverage the capabilities of VMware AirWatch and Intercede solutions is low impact to the user, easy to use and will assist government departments in managing who has access to privileged data."

Intercede and Imagination are providing a demonstration of the 'Trust Continuum' at BT's Innovation 2017 event. The demonstration focuses on how systems-on-chips (SoCs) for home gateway routers can be architected to address the growing security and management challenges presented by the proliferation of Internet of Things (IoT) devices, services and technologies entering the home. It is based on a MIPS-based platform which supports multiple isolated Trusted Runtime Environments (TREs) where services, including the network communication standards they rely upon, can be provisioned and managed by the operator. This is enabled by the powerful hardware virtualization capabilities of the MIPS CPU and the security-focused evolution of Intercede's MyTAM® client and mobile app, which enables service providers to dynamically created TREs and to deploy trusted applications directly into them.

More details of Intercede's contribution to BT Innovation 2017 can be found at https://www.intercede.com/news/bt-intercede-and-imagination-collaborate-on-iot-security/.

Richard Parris, Chairman & CEO of Intercede, commented on Intercede's work with Imagination;

"This is another example of how Intercede's software is forming a vital component of key eco-systems, both now and for future development. Systems-on-Chips will be integral to the Internet of Things, particularly in light of the growing management and security issues thrown up by the proliferation of IoT devices, services and technologies entering the home."

 

Contact

Intercede Group plc

Tel: +44 (0) 1455 558 111

Richard Parris

Chairman & Chief Executive

Andrew Walker

Finance Director

finnCap

Tel: +44 (0) 20 7220 0500

Stuart Andrews

Corporate Finance

Simon Hicks

Corporate Finance

Steve Norcross

Corporate Broking

Capital Access Group

Tel: +44 (0) 20 3763 3400

Scott Fulton

Media

Ed Welsby

Investors

 

About Intercede

Intercede is a software and service company specializing in identity, credential management and secure mobility. Its solutions create a foundation of trust between connected people, devices and apps and combine expertise with innovation to provide world-class cybersecurity. Intercede has been delivering solutions to high profile customers, from the US and UK governments to some of the world's largest corporations, telecommunications providers and information technology firms, for over 20 years. Intercede's product portfolio includes MyID, an identity and credential management system that assigns trusted digital identities to employees citizens and machines. In 2015, Intercede launched MyTAM, enabling trusted applications to be loaded into a mobile device's Trusted Execution Environment (TEE), providing hardware-level security for Android apps. In 2016, Intercede launched RapID, a secure, easy to implement authentication service for mobile apps and cloud services to completely eliminate the need for passwords.

For more information visit: www.intercede.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUUSNRBNANAAR
Date   Source Headline
7th Nov 20237:00 amRNSContract and Renewals Orders
25th Oct 20234:44 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSNotice of Interim Results & Investor Presentation
20th Oct 20237:03 amRNSAppointment of Non-Executive Director
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSTrading Update
21st Sep 20231:31 pmRNSResult of AGM
4th Sep 20237:00 amRNSContract and Renewals Orders
30th Aug 20237:10 amRNSNotice of AGM and Publication of Annual Report
20th Jun 20237:01 amRNSBoard Changes
20th Jun 20237:00 amRNSFinal Results
12th Jun 20237:00 amRNSNotice of Results & Investor Presentation
27th Apr 20237:00 amRNSShare Incentive Plan
17th Apr 20237:00 amRNSTrading Update
3rd Apr 20237:00 amRNSContract wins/renewals
3rd Feb 202310:46 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSChange of Auditors
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20232:00 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSTrading Update
11th Jan 20232:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20228:45 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSHalf-year Report
11th Nov 20227:00 amRNSNotice of Interim Results & Investor Presentation
13th Oct 202210:30 amRNSDirector/PDMR Shareholding
11th Oct 20221:00 pmRNSDirector/PDMR Shareholding
10th Oct 20228:00 amRNSLong Term Incentive Plan
10th Oct 20227:01 amRNSAcquisition of Authlogics Ltd
10th Oct 20227:00 amRNSTrading Update
28th Sep 202212:22 pmRNSResult of AGM
15th Sep 20227:00 amRNSDirector/PDMR Shareholding and Issue of Equity
10th Aug 20227:00 amRNSNotice of AGM
30th Jun 20227:00 amRNSBoard Changes
8th Jun 20227:00 amRNSFinal Results
25th May 202210:15 amRNSInvestor Presentation
12th Apr 20227:00 amRNSAppointment of CFO
6th Apr 20227:00 amRNSDirector/PDMR Shareholding
5th Apr 20227:00 amRNSTrading Update & Contract Win
30th Mar 202210:01 amRNSReceipt of $3.4m Order
2nd Feb 20227:00 amRNSContract Win
8th Dec 20213:55 pmRNSDirector/PDMR Shareholding and Issue of Equity
23rd Nov 20217:00 amRNSHalf-year Report
19th Nov 20217:00 amRNSHolding(s) in Company-Amendment
17th Nov 20217:00 amRNSInvestor Presentation
16th Nov 20217:00 amRNSHolding(s) in Company
15th Nov 20213:45 pmRNSTotal Voting Rights
11th Nov 20214:12 pmRNSHolding(s) in Company
11th Oct 20217:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.